Pinnacle Associates’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEN
AIM
NAMA
RSCM
TFCM
Pinnacle Associates's CGEN Position: Q2 2022 in Review
Pinnacle Associates sold out of Compugen (CGEN) in Q2 2022, closing a stake of 20,000 shares — an estimated $64K sold.
Pinnacle Associates first reported a position in CGEN in Q1 2021 and held it in 5 quarters. The position peaked at $119K in Q1 2021. 89 funds tracked by Wall St. Rank hold CGEN as of Q2 2022.
- Pinnacle Associates reported no remaining Compugen position as of Q2 2022 after selling out during the quarter.
- Pinnacle Associates sold 20,000 Compugen shares in Q2 2022, an estimated $64K.
- Pinnacle Associates first reported a position in Compugen in Q1 2021 and held it in 5 quarters.
- Pinnacle Associates's Compugen position peaked at $119K in Q1 2021.
- 89 funds tracked by Wall St. Rank held Compugen as of Q2 2022.
Based on Pinnacle Associates's 13F filing for Q2 2022, filed 2 Aug 2022.